Ethyl 4-[(6-substituted 2,2-dimethyl-2H-chromen-7-yl)methoxy]benzoates and their analogues were prepared and the biological activities were evaluated for both anti-juvenile hormone (anti-JH) and JH activity in silkworm larvae, Bombyx mori. Of the compounds tested, ethyl 4-[(6-methoxy-2,2-dimethyl-2H-chromen-7-yl)methoxy]-benzoate (3b) showed the most effective precocious metamorphosis-inducing activity in 3rd instar larvae and JH activity in allatectomized 4th instar larvae. Furthermore, JH I and 20-hydroxyecdysone (20-E) titers in hemolymph of 3rd instar larvae treated with 3b were measured by liquid chromatography-mass spectrometry (LC-MS) and LC-MS/MS, respectively. The results revealed that compound 3b induced precocious metamorphosis by specifically decreasing JH I in hemolymph.
Introduction
Juvenile hormones (JHs) are a class of regulatory sesquiterpenoids that play a crucial role in metamorphosis, diapause in immature insects and reproduction in adult insects. In the larval stage, molting and metamorphosis are regulated by JHs and ecdysteroid (molting hormone). 1) JHs suppress adult differentiation and favor the maintenance of larval structures. A high titer of JHs must be present in the hemolymph for immature larvae to grow and pass through a series of larval molts induced by ecdysteroid secretion. Since JHs are involved in a wide range of physiological processes in insects, anti-JH agents, which interfere with the actions of JHs in insects, could be an effective tool for studies on insect physiology as well as a potential insect growth regulator (IGR).
2) Many anti-JH agents, including precocenes, ethyl 4-[2-(tert-butylcarbonyloxy)butyloxy]benzoate (ETB) and brevioxime 3) have been reported. We have also found that ethyl 4-(2-benzylhexyloxy)benzoate (KF-13), by modifying the structure of ETB, strongly induced precocious metamorphosis against silkworm larvae, Bombyx mori. 4) This study is an attempt to design and synthesize a new scaffold of anti-JH agents. We focused on the similarities in structures between JHs and retinoic acid. Interestingly, Palli and et al. have reported that two retinoic acid agonists showed weak JH activity in the black Manduca larval bioassay. 5) A number of compounds having a 1,2,3,4-tetrahydro-1,1,4,4-tetramethynaphthalene ring are known as retinoid agonists or antagonists. 6 ) Therefore, chromene derivatives having an oxygen atom in a 6-membered ring were designed on the basis of comparison of the structure of retinoids and JHs (Fig. 1) , and their precocious metamorphosis-inducing activity against silkworm larvae was evaluated. In this paper, we described the preparation and structure-activity relationship of ethyl 4-[(6-substituted 2,2-dimethyl-2H-chromen-7-yl)methoxy]benzoates (1) and related derivatives, and furthermore, the effect of a representative compound, ethyl 4-[(6-methoxy-2,2-dimethyl-2H-chromen-7-yl)methoxy]benzoate (3b), on JH I, the major JH in silkworm larvae, and 20-hydroxyecdysone (20-E) titers in hemolymph.
Materials and Methods

Instrumental Analysis and Chemicals
1 H NMR spectra were determined with a JEOL EX-400 (400 MHz) spectrometer, using tetramethylsilane as an internal standard, and all samples were prepared in deuteriochloroform. Methoprene was kindly supplied by Earth Biochemical Co.
2,2-Dimethyl-2H-chromene-7-carbaldehyde (2a)
To a solution of 2-methyl-3-butyn-2-ol (1.0 g, 12 mmol) in acetonitrile (10 ml) was added DBU (2.71 g, 18 mmol) and trifluoroacetic anhydride (2.75 g, 18 mmol) at Ϫ5°C. After the mixture was stirred for 30 min at the same temperature, a prepared solution of 3-hydroxybenzaldehyde (1.45 g, 12 mmol), DBU (2.71 g, 18 mmol) and CuC1 2 (10 mg) dissolved in acetonitrile (10 ml) at Ϫ5°C was added. Stirring was continued for 3 h at the same temperature, the product was extracted with ethyl acetate, and the extract was washed with 2 N aq. HCl, 2 N aq. NaOH and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexane-ethyl acetate (20 : 1) to give 1.26 g crude propynyl ether as a dark brown oil. A solution of the above ether (1.26 g) in N,N-diethylaniline (10 ml) was stirred for 2 h at 180°C. The product was extracted with ethyl acetate and the extract was washed with 2 N aq. HCl and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexane-ethyl acetate (20 : 1) to give 0.12 g (6%; in two steps) of 2a as a yellow oil. 
6-Methoxy-2,2-dimethyl-2H-chromene-7-carbaldehyde (2b)
A solution of phosphoryl chloride (6.04 g, 39 mmol) in DMF (2.88 g, 39 mmol) was stirred for 30 min at 0°C. To the mixture was added a solution of 6-methoxy-2,2-dimethyl-2H-chromene (0.75 g, 3.9 mmol) in DMF (2 ml). After stirring for 8 h at 80°C, the reaction was quenched with 2 N aq. NaOH at 0°C. The product was extracted with ethyl acetate and the extract was washed with 2 N aq. HCl and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexaneethyl acetate (8 : 1) to give 0.32 g of 2b, which was an approximately 5 : 1 mixture of 7-CHO and 5-CHO isomers.
Compounds 2c-e were prepared in the same manner as described above starting from the corresponding 6-alkyloxychromenes.
Ethyl 4-[(2,2-dimethyl-2H-chromen-7-yl)methoxy]benzoate (3a)
To a solution of 2a (0.12 g, 0.64 mmol) in methanol (10 ml) was added NaBH 4 (0.02 g, 0.64 mmol) at room temperature. After stirring for 1 h, the product was extracted with ethyl acetate and the extract was washed with water and brine, dried over Na 2 SO 4 and concentrated to give 0.12 g of crude 2,2-dimethyl-2H-chromene-7-methanol.
To a solution of the above alcohol (0.12 g) in THF (5 ml) was added Ph 3 P (0.25 g, 0.95 mmol), 40% diisopropyl azodicarboxylate (0.48 g, 0.95 mmol) dissolved in toluene and ethyl p-hydroxybenzoate (0.13 g, 0.95 mmol) at 0°C. After stirring for 16 h at room temperature, the product was extracted with ethyl acetate. The extract was washed with 2 N aq. NaOH and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexane-ethyl acetate (20 : 1) to give 0.02 g (9%) of 3a as a colorless oil. 1 
Ethyl 4-[(6-methoxy-2,2-dimethylchroman-7-yl)methoxy]-benzoate (4)
A solution of 6-methoxy-2,2-dimethyl-2H-chromene-7-methanol (0.15 g, 0.68 mmol) in methanol (5 ml) containing Pd/C (0.01 g) was stirred for 16 h at room temperature under a hydrogen atmosphere. After filtration, the product was extracted with ethyl acetate. The extract was washed with water and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexane-ethyl acetate (3 : 1) to give 0.15 g of crude 6-methoxy-2,2-dimethylchroman-7-methanol.
To a solution of the above alcohol (0.15 g) in THF (5 ml) at 0°C was added Ph 3 P (0.37 g, 1.4 mmol), 40% diisopropyl diazocarboxylate in toluene (0.71 g, 1.4 mmol) and ethyl p-hydroxybenzoate (0.20 g, 1.2 mmol). After stirring for 16 h at room temperature, the product was extracted with ethyl acetate and the extract was washed with 2 N aq. NaOH and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexane-ethyl acetate (10 : 1) to give 0.14 g (43% in two steps) of 4 as a colorless oil. 
7-Methoxy-1,4-benzodioxan-6-carbaldehyde (6a)
To a solution of 6-hydroxy-1,4-benzodioxane (5a, 1.05 g, 7 mmol) in THF (10 ml) at 0°C was added 2.0 M ethyl magnesium chloride in THF (17.3 ml, 36 mmol), and the mixture was stirred for 30 min at room temperature. After removing the solvent under reduced pressure, the residue was dissolved in benzene (10 ml) and hexamethylphosphoric triamide (3.09 g, 17 mmol), and cooled at 0°C. Paraformaldehyde (3.0 g) was added to the mixture. After stirring for 4 h at 80°C, the product was extracted with ethyl acetate and the extract was washed with 2 N aq. HCl and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexaneethyl acetate (3 : 1) to give 0.64 g crude 7-hydroxy-1,4-benzodioxan-6-carbaldehyde.
To a solution of the above aldehyde (0.15 g) in DMF 10 ml was added K 2 CO 3 (0.12 g, 0.9 mmol) and methyl iodide (0.13 g, 0.9 mmol). After stirring for 4 h at 80°C, the product was extracted with ethyl acetate and the extract was washed with 2 N aq. NaOH and brine, dried over Na 2 SO 4 and concentrated. The residue was purified by column chromatography on silica gel by eluting with n-hexane-ethyl acetate (7 : 1) to give 1.05 g (78% in two steps) of 6a as a pale yellow oil. 1 
Biological Evaluation
B. mori (ShunreiϫShougetsu) larvae were reared on an artifi-Journal of Pesticide Science cial diet.
7) The anti-JH activity of compounds was evaluated by the induction of precocious metamorphosis when topically applied to the dorsal abdomen of 24-hr-old 3rd instar larvae. The JH activity of compounds was evaluated by molting into normal 5th instars when topically applied to allatectomized 24-hr-old 4th instar larvae. 8) 
Quantification of JH and 20-E in hemolymph
3.1. Reagents and glassware JH I and II were purchased from SciTech (Prague, Czech Republic) and JH III was from Sigma-Aldrich (St. Louis, MO), respectively, and purified by LC-MS with a silica gel column (SG-80, 10ϫ250 mm; Shiseido, Tokyo, Japan) using 10% diethyl ether in n-hexane as the normal phase. Deuterium-labeled JH III (JH III-d 3 ) as the internal standard was prepared according to the previous report.
9) 20-Hydroxyecdysone and ponasterone A were purchased from Sigma-Aldrich.
All solvents used were of residual pesticide analysis grade (5000-fold concentrate guaranteed; Wako Pure Chemicals, Osaka, Japan). All glassware was rinsed sequentially with distilled water, acetone and n-hexane, and heated overnight at 500°C before use.
Collection of hemolymph samples
Ten micrograms of compound 3b in acetone solution (1 m l) was applied topically to 24-hr-old 3rd instar of B. mori larvae. An abdominal leg was cut and hemolymph was collected in microtubes containing approx. 5% (w/v) phenylthiourea and 1 mM EDTA every 24 hr. Samples were stored at Ϫ80°C until used.
Purification of JH I from hemolymph and analytical
conditions for LC-MS Clean-up was carried out by slightly modifying the method described for JH quantification using GC-MS. 10 ) Briefly, 10 m l JH III-d 3 in toluene (67.1 pg/m l) as an internal standard was transferred into a clean glass tube, and 0.5 ml methanol was added. To this solution was added the hemolymph (100 m l), the mixture was vortexed vigorously, and 1.5 ml of 2% NaCl solution was added to the sample solution. JHs were extracted by the partition of n-hexane (0.5 ml) three times. The combined extracts (1.5 ml) were purified using a Pasture pipette packed with 1.0 g aluminum oxide (activity grade III; ICN Ecochrom, Germany) prewashed with n-hexane. After loading the extract, JH I was eluted with 2 ml of 50% ether in nhexane and then the solvent was removed under a stream of nitrogen. The residue was dissolved in acetonitrile (25 m l).
The Applied Biosystems API2000 LC-MS system was used. The analytical condition was optimized referring to the method reported previously.
11) The samples were separated on a 3ϫ150 mm C 18 reversed phase column (UG80; Shiseido) with 70% acetonitrile containing the appropriate sodium salt at a flow rate of 0.4 ml/min. For MS analysis, electrospray ionization (ESI) in the positive mode was used under the conditions of drying gas temperature 400°C with 10 l/min flow rate and 15 V declustering potential (DP). Selected ion masses (SIM) for each JH were monitored as [MϩNa] ϩ , that is, m/z 292 and 317 for JH III-d 3 and JH I, respectively.
Purification of 20-E from hemolymph and analytical condition for LC-MS/MS
Ponasterone A (5 ng/m l) in 10 m l methanol as an internal standard was transferred into a microtube, and 300 m l methanol was added. To this solution was added the hemolymph (20 m l), and the mixture was vortexed vigorously and centrifuged at 13000 rpm for 10 min. The supernatant was collected in new microtubes, and the pellet was re-extracted with 300 m l methanol. The combined methanol extracts (600 m l) were evaporated to dryness under a vacuum. The residue was dissolved in 100 m l of 80% methanol in water.
The Applied Biosystems API2000 LC-MS/MS system equipped with a 3ϫ150 mm C 18 reversed phase column (MG80; Shiseido) was used. The solvents were deionized water containing 0.01% formic acid (solvent A) and acetonitrile.
12) A linear solvent gradient was used starting from 5% acetonitrile in solvent A to 100% acetonitrile over 15 min, followed by elution with 100% acetonitrile for 5 min at a flow rate of 0.3 ml/min. For MS/MS analysis, ESI in the positive mode with nitrogen as collision gas was used under the conditions of drying gas temperature 500°C with 10 l/min flow rate. 
Results and Discussion
Synthesis
The synthesis of a series of ethyl 4-[(6-substituted 2,2-dimethyl-2H-chromen-7-yl)methoxy]benzoates and related derivatives is outlined in Fig. 2(A) and (B). Chromene 2a was prepared via alkylation of 3-hydroxybenzaldehyde with 2-methyl-3-butyn-2-ol and trifluoroacetic anhydride in the presence of DBU and CuCl 2 , and cyclization under heating in N,N-dimethylaniline at 180°C. 13) 6-Substituted chromene (I) was formylated by the Vilsmeier procedure, and aldehydes 2b-e were yielded as approximately 5 : 1 mixtures of 7-CHO and 5-CHO isomers. In the case of phenols 5a-c, formylation 14) was carried out via the magnesium chloride salt of the phenol to yield the o-hydroxyaldehyde exclusively, which was treated with methyl iodide to afford aldehydes 6a-c. Reduction of the aldehyde group in 2a-e and 6a-c with NaBH 4 , followed by the Mitsunobu reaction with ethyl p-hydroxybenzoate gave compounds 3a-e and 7a-c, respectively. Table 1 shows the precocious metamorphosis-inducing activity of ethyl 4-[(6-substituted 2,2-dimethyl-2H-chromen-7-yl)-methoxy]benzoates and related compounds against 3rd instar larvae of B. mori. Compound 3a showed weak precocious metamorphosis-inducing activity. Introduction of a methoxy group at 6-position on the chromene ring (3b) led to the marked increase of anti-JH activity, showing 100% induction of precocious metamorphosis at 40 m g; however, when a longer alkyloxy substituent, such as an ethoxy (3c) and a npropoxy (3d) group, was introduced, their anti-JH activity was markedly decreased. Interestingly, the benzyloxy analog 3e exhibited almost the same level of activity as 3b, suggesting that the size of the substituent of C-6 on the chromene ring was significantly not a critical factor for anti-JH activity.
Anti-JH activity of chromenes and related compounds
Precocene II possessing a 2,2-dimethyl-2H-chromene skeleton was the first compound to show anti-JH activity. 15) Concerning its mode of action, the double bond of the chromene ring is readily oxidized by P450 in the corpora allata to the epoxide intermediate, a powerful alkylating property, which reacts with cellular macromolecular constituents to destroy the cells of the corpora allata. Therefore, in precocene II, the double bond is indispensable for anti-JH activity. To examine whether the double bond in the chromene ring of 3b was essential for anti-JH activity, the chroman derivative 4 was synthesized. Chroman 4 showed slightly lower anti-JH activity than the corresponding chromene 3b, suggesting that the mode of action of these derivatives is different from that of precocene II. Benzodioxan derivative 7a showed somewhat lower activity than those of 3b and 4. On the other hand, the anti-JH activity of tetraline derivative 7b was markedly decreased, and 4,5-dimethoxy derivative 7c did not show any activity. These results indicate that the ring structure containing an oxygen atom adjacent to the benzene ring is significant for anti-JH activity. Table 2 shows the JH activity of methoprene, chromene 3b and chroman 4 against allatectmized 4th instar larvae. All allatectomized and acetone-treated control larvae underwent Vol. 35, No. 4, 405-411 (2010) Anti-juvenile hormone activity of chromene derivatives 409 precocious metamorphosis. Compounds 3b and 4 as well as methoprene completely prevented precocious metamorphosis at a high dose of 40 m g so that all treated larvae molted into 5th larvae. The JH activity of compound 3b at 1 m g was lower than that of methoprene. Thus, in analogy with the ethyl 4-(2-benzylalkyloxy)benzoate series, 4) these compounds were found to show both anti-JH and JH activity.
JH activity of chromene and chroman derivatives
Changes in JH I and 20-E titers in hemolymph after
topical application of compound 3b The JH I titer in hemolymph of larvae treated with 10 m g compound 3b was determined by LC-MS from the day when treated to 3rd instar larvae through pupation (Fig. 3A) . In controls, the JH I titer decreased just before ecdysis to 4th instar, and sharply increased to as high as 4.60Ϯ2.02 ng/ml after ecdysis. In contrast to the results obtained by radioimmunoassay, 16) no JH I was observed in the early stage of 5th larvae. Topical application of compound 3b caused a marked drop in the JH I titer within 24 hr after treatment and JH I was not detected (Ͻ0.1 ng/ml) prior to precocious metamorphosis at the end of the 4th instar, but just before pupation, an increase in JH I levels (1.68Ϯ1.50 ng/ml) was observed. Although, in this case, the JH I titer had already decreased in the hemolymph of 3rd-instar larvae, precocious metamorphosis always occurred in the 4th stadium, suggesting that anti-JH activity of compound 3b was counteracted by JH activity of 3b itself, present in high concentration during the 3rd stadium.
As previously described, precocious metamorphosis is well known to be induced by JH deficiency in the larval stage; however, we have found that the precocious metamorphosisinducing activity of some 1,5-disubstituted imidazoles is completely reversible by the dietary administration of 20-E, suggesting that a temporary decline of ecdysteroid titers in the larval hemolymph might also cause precocious methamorphosis. 17) We therefore determined the 20-E titer in hemolymph by LC-MS/MS. Compound 3b had no significant effect on the 20-E titer during the 3rd stadium (Fig. 3B) . Furthermore, the 20-E titer in 4th instar larvae treated with compound 3b showed a profile very similar to that in control 5th instar larvae before pupation. These results indicate that compound 3b induced precocious metamorphosis by decreasing JH levels in hemolymph of 3rd and 4th instar larvae.
In conclusion, we found that ethyl 4-[(6-methoxy-2,2-dimethyl-2H-chromen-7-yl)methoxy]benzoate (3b) was a structurally novel anti-JH agent. Although compound 3b showed JH activity as well as anti-JH activity, it clearly decreased the JH I titer in hemolymph. Compound 3b is therefore a reasonable lead compound for the generation of genuine anti-JH agents showing no JH activity.
